- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03402243
Effect of Banning Menthol Flavorant on Cigarette and E-Cigarette Use
July 16, 2021 updated by: University of Minnesota
In this pilot study, menthol cigarette smokers will be randomized to one of three experimental marketplaces: 1) a condition simulating a ban on menthol cigarettes but not menthol e-cigarettes (condition A); 2) a condition simulating a ban on both menthol cigarettes and menthol e-cigarettes (Condition B); and 3) a condition in which menthol is not banned for either product (Condition C - the control condition).
All conditions would have medicinal nicotine available if subjects decide to quit tobacco products entirely.
At visits occurring every two weeks over a 6 week period, subjects will receive "credits" that they could exchange for any product available in their randomized marketplace condition.
Outcomes include the amount of each tobacco product used.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
47
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- Clinical and Translational Sciences Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 64 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Be between the ages of 18 and 64
- Purchase exclusively menthol cigarettes
- Not currently motivated to quit smoking
- Smoking a minimum number of cigarettes per day
Exclusion Criteria:
- Report a serious, unstable medical or psychiatric condition
- Use any medications that might interfere with measures to be studied (for example, medications known to affect smoking)
- Have used any smoking cessation therapy during the past month
- Regularly use any form of tobacco other than cigarettes
- Are pregnant or breast feeding or planning to become pregnant or breast feed during the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Menthol ban only for cigarettes
Participants will have available to them non-menthol cigarettes, menthol and tobacco flavored versions of a cigarette-like e-cigarette, menthol and tobacco flavored versions of a tank like e-cigarette and nicotine gum and lozenge
|
Participants will have menthol and tobacco flavored e-cigarettes available but only non-menthol cigarettes
|
EXPERIMENTAL: Menthol ban for cigarettes and e-cigarettes
Participants will have available to them non-menthol cigarettes, tobacco flavored version of a cigarette-like e-cigarette, tobacco flavored version of a tank like e-cigarette and nicotine gum and lozenge
|
Participants will have neither menthol flavored cigarettes or e-cigarettes available
|
OTHER: No Menthol Ban
Participants will have available to them menthol and non-menthol cigarettes, menthol and tobacco flavored versions of a cigarette-like e-cigarette, menthol and tobacco flavored versions of a tank like e-cigarette and nicotine gum and lozenge
|
Participant will have menthol and tobacco flavored cigarettes and e-cigarettes available
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Amount of Tobacco Product Used
Time Frame: 6 weeks
|
Total number of cigarettes smoked and puffs of e-cigarettes used
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
How Much of Each Product is Obtained From the "Experimental Marketplace"
Time Frame: 6 weeks
|
Number of packs of cigarettes obtained and amount of e-liquid obtained from the "experimental marketplace"
|
6 weeks
|
Motivation to Quit Smoking Cigarettes
Time Frame: 6 weeks
|
Based on a question asking how motivated from 1 (not at all) to 10 (extremely) the participant is to quit smoking cigarettes at this time
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 26, 2018
Primary Completion (ACTUAL)
March 25, 2020
Study Completion (ACTUAL)
March 25, 2020
Study Registration Dates
First Submitted
January 9, 2018
First Submitted That Met QC Criteria
January 16, 2018
First Posted (ACTUAL)
January 18, 2018
Study Record Updates
Last Update Posted (ACTUAL)
August 10, 2021
Last Update Submitted That Met QC Criteria
July 16, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R03DA045150 (NIH)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
No identifiable information will be shared with other researchers
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tobacco Use Disorder
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Nicotine Dependence | Tobacco Dependence | Smoking, Tobacco | Nicotine Use Disorder | Nicotine Dependence, Cigarettes | Smoking, Cigarette | Nicotine Dependence Tobacco Product | Tobacco; Use, Rehabilitation | Smoking (Tobacco) Addiction and other conditionsUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)RecruitingTobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Tobacco DependenceUnited States
-
Harvard School of Public Health (HSPH)Beacon Communities; The Community BuildersEnrolling by invitationTobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Second Hand Tobacco SmokeUnited States
-
University of California, San FranciscoNational Institute on Minority Health and Health Disparities (NIMHD)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Tobacco Dependence | Smoking, Tobacco | Smoking, CigaretteUnited States
-
University of California, San FranciscoTobacco Related Disease Research ProgramCompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Tobacco Dependence | Smoking, Tobacco | Smoking, CigaretteUnited States
-
New York State Psychiatric InstituteTerminatedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Disorder | Nicotine Dependence | Cigarette Smoking | Tobacco Dependence | Nicotine Use Disorder | Smoking, CigaretteUnited States
-
Rutgers, The State University of New JerseyNational Institute on Drug Abuse (NIDA)CompletedSchizophrenia | Schizoaffective Disorder | Tobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use CessationUnited States
-
University of PennsylvaniaFood and Drug Administration (FDA)Completed
-
University of Kansas Medical CenterCompletedTobacco Use Disorder/Cigarette SmokingUnited States
-
Ottawa Hospital Research InstituteCompletedTobacco Use Disorder | Tobacco Use Cessation | Tobacco Dependence
Clinical Trials on Menthol ban on cigarettes
-
Yale UniversityRecruiting
-
Ohio State University Comprehensive Cancer CenterNational Institute on Drug Abuse (NIDA); Brown University; National Institutes... and other collaboratorsCompletedSmoking (Tobacco) AddictionUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); University of MinnesotaRecruitingSmoking Prevention and ControlUnited States
-
University of MinnesotaCompleted
-
22nd Century Group, Inc.CelerionCompletedTobacco UseUnited States
-
22nd Century Group, Inc.Vince & Associates Clinical Research, Inc.CompletedTobacco UseUnited States
-
Federal University of the Valleys of Jequitinhonha...Fundação de Amparo à Pesquisa do estado de Minas GeraisNot yet recruitingChild Development
-
Milton S. Hershey Medical CenterNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); Food and Drug Administration (FDA)CompletedTobacco Smoking BehaviorUnited States
-
R.J. Reynolds Vapor CompanyCovance; R.J. Reynolds Tobacco Company; MAS (Materials Analytical Services), LLCCompleted